Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Colinz Laboratories Ltd

NSE: COLINZ · BSE: 531210 · Pharmaceuticals & Biotechnology · 24 announcements

Share price
₹71.80
Market cap
₹18.09 Cr
Revenue (annual)
₹6.14 Cr
Net profit (annual)
₹0.51 Cr
P/E (TTM)
6.5×Sector 47.4×
Promoter holding
50.60%-15.40% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

12:18 IST BSE
Debt & Borrowing

Colinz Laboratories Debt & Borrowing

Colinz Laboratories Ltd confirmed it is not identified as a Large Corporate for the financial year ended March 31, 2026. Consequently, the company is not required to file initial or annual disclosures under the SEBI framework for fund raising by issuance of debt securities.